Skip to main content

Table 3 Data for subjects related to the time of normalization of PSA < 2 ng/mL

From: Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer

 

Normalization of PSA to < 2 ng/mL

Time to normalization (d) * (n = 119)

289 ± 15

IMRT with or without NAAD*

 

   With NAAD (n = 54)

298 ± 24

   Without NAAD (n = 26)

303 ± 33

IMRT Boost*

 

   Yes (n = 28)

308 ± 25

   No (n = 91)

283 ± 18

Tumor Stage*

 

   T1c (n = 90)

280 ± 15 b

   T2, T2a, T2b, T2c (n = 21)

375 ± 42 a

   T3, T3a, T3b (n = 6)

154 ± 33 c

Correlation to time of normalization of PSA

 

   Age at time of CT (n = 108)

-0.12

   Length of hormone trt (n = 50)

0.22

   Gleason Score (n = 119)

-0.13

   Pre-PSA (n = 119)

-0.17

  1. Abbreviation: PSA = Prostate specific antigen; NAAD = Neoadjuvant androgen deprivation therapy; IMRT = intensity modulated radiation therapy
  2. * mean ± SEM
  3. † correlation coefficient
  4. ‡ p < 0.05
  5. § values in a column followed by a different letter are significantly different (p < 0.05)